Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The antiherpetic drug acyclovir inhibits HIV replication and selects the V75I reverse transcriptase multidrug resistance mutation.
McMahon MA, Siliciano JD, Lai J, Liu JO, Stivers JT, Siliciano RF, Kohli RM.
J Biol Chem. 2008 Nov 14;283(46):31289-93. doi: 10.1074/jbc.C800188200. Epub 2008 Sep 24.
Similar articles
Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy.
Balzarini J.
Biochem Pharmacol. 1999 Jul 1;58(1):1-27. Review.
[Resistance of herpes simplex viruses to antiviral drugs].
Scieux C, Bianchi A.
Pathol Biol (Paris). 1993 Feb;41(2):172-7. Review. French.
Herpes simplex virus resistance to antiviral drugs.
Morfin F, Thouvenot D.
J Clin Virol. 2003 Jan;26(1):29-37. Review.
[Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F, Frobert E, Thouvenot D.
Ann Biol Clin (Paris). 2003 Jan-Feb;61(1):33-40. Review. French.
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J, MartÃnez MA.
Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4. Review.
Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
Rezende LF, Prasad VR.
Int J Biochem Cell Biol. 2004 Sep;36(9):1716-34. Review.
Structural and biochemical effects of human immunodeficiency virus mutants resistant to non-nucleoside reverse transcriptase inhibitors.
Domaoal RA, Demeter LM.
Int J Biochem Cell Biol. 2004 Sep;36(9):1735-51. Review.
Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ, Bacon TH, Leary JJ.
Clin Infect Dis. 2004 Nov 1;39 Suppl 5:S248-57. Review.
Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC Jr, Kessler HA.
Infect Agents Dis. 1995 Sep;4(3):115-24. Review.
Herpes simplex encephalitis : from virus to therapy.
Rozenberg F, Deback C, Agut H.
Infect Disord Drug Targets. 2011 Jun;11(3):235-50. Review.
The challenge of antiretroviral-drug-resistant HIV: is there any possible clinical advantage?
Zaccarelli M, Tozzi V, Perno CF, Antinori A.
Curr HIV Res. 2004 Jul;2(3):283-92. Review.
New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo.
McMahon MA, Shen L, Siliciano RF.
Curr Opin Infect Dis. 2009 Dec;22(6):574-82. doi: 10.1097/QCO.0b013e328332c54d. Review.
Filters: Manage Filters